286 related articles for article (PubMed ID: 30971426)
21. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
[TBL] [Abstract][Full Text] [Related]
22. Retroviral DNA Integration.
Lesbats P; Engelman AN; Cherepanov P
Chem Rev; 2016 Oct; 116(20):12730-12757. PubMed ID: 27198982
[TBL] [Abstract][Full Text] [Related]
23. In vitro HIV-1 selective integration into the target sequence and decoy-effect of the modified sequence.
Tsuruyama T; Nakai T; Hiratsuka T; Jin G; Nakamura T; Yoshikawa K
PLoS One; 2010 Nov; 5(11):e13841. PubMed ID: 21079805
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
[TBL] [Abstract][Full Text] [Related]
25. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.
Esposito D; Craigie R
EMBO J; 1998 Oct; 17(19):5832-43. PubMed ID: 9755183
[TBL] [Abstract][Full Text] [Related]
26. Nucleoprotein complex intermediates in HIV-1 integration.
Li M; Craigie R
Methods; 2009 Apr; 47(4):237-42. PubMed ID: 19232539
[TBL] [Abstract][Full Text] [Related]
27. Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.
Leavitt AD; Rose RB; Varmus HE
J Virol; 1992 Apr; 66(4):2359-68. PubMed ID: 1548767
[TBL] [Abstract][Full Text] [Related]
28. Pre-organized structure of viral DNA at the binding-processing site of HIV-1 integrase.
Renisio JG; Cosquer S; Cherrak I; El Antri S; Mauffret O; Fermandjian S
Nucleic Acids Res; 2005; 33(6):1970-81. PubMed ID: 15814814
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the activity of HIV-1 integrase over-expressed in eukaryotic cells.
Van Maele B; Van Eylen L; Pluymers W; Debyser Z
Biochem Biophys Res Commun; 2005 Feb; 327(1):261-7. PubMed ID: 15629457
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of human flap endonuclease 1 by human immunodeficiency virus type 1 integrase: possible role for flap endonuclease 1 in 5'-end processing of human immunodeficiency virus type 1 integration intermediates.
Faust EA; Triller H
J Biomed Sci; 2002; 9(3):273-87. PubMed ID: 12065902
[TBL] [Abstract][Full Text] [Related]
31. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD
Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997
[TBL] [Abstract][Full Text] [Related]
32. Retroviral DNA integration: reaction pathway and critical intermediates.
Li M; Mizuuchi M; Burke TR; Craigie R
EMBO J; 2006 Mar; 25(6):1295-304. PubMed ID: 16482214
[TBL] [Abstract][Full Text] [Related]
33. Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase.
Chow SA; Brown PO
J Virol; 1994 Dec; 68(12):7869-78. PubMed ID: 7966577
[TBL] [Abstract][Full Text] [Related]
34. Target DNA capture by HIV-1 integration complexes.
Miller MD; Bor YC; Bushman F
Curr Biol; 1995 Sep; 5(9):1047-56. PubMed ID: 8542281
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
Richetta C; Subra F; Malet I; Leh H; Charpentier C; Corona A; Collin G; Descamps D; Deprez E; Parissi V; Calvez V; Tramontano E; Marcelin AG; Delelis O
J Virol; 2022 Jul; 96(14):e0067622. PubMed ID: 35758669
[TBL] [Abstract][Full Text] [Related]
36. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro.
Ellison V; Brown PO
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7316-20. PubMed ID: 8041787
[TBL] [Abstract][Full Text] [Related]
37. In vitro assays for activities of retroviral integrase.
Chow SA
Methods; 1997 Aug; 12(4):306-17. PubMed ID: 9245611
[TBL] [Abstract][Full Text] [Related]
38. Substrate specificity of recombinant human immunodeficiency virus integrase protein.
LaFemina RL; Callahan PL; Cordingley MG
J Virol; 1991 Oct; 65(10):5624-30. PubMed ID: 1895409
[TBL] [Abstract][Full Text] [Related]
39. Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
Dicker IB; Terry B; Lin Z; Li Z; Bollini S; Samanta HK; Gali V; Walker MA; Krystal MR
J Biol Chem; 2008 Aug; 283(35):23599-609. PubMed ID: 18577511
[TBL] [Abstract][Full Text] [Related]
40. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
